Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner. Impel NeuroPharma is currently investigating INP104 (POD™ DHE) for acute migraine headache, INP103 (POD™ levodopa) for Parkinson's Disease, INP105 (POD™ olanzapine) for agitation in schizophrenia and bipolar disorders as well as INP102 (POD™ insulin) for Alzheimer's disease in an NIH funded trial. Impel NeuroPharma's proprietary POD™ device enables small and large molecule drugs to be administered using a cost-effective, disposable, non-invasive intranasal drug delivery device. To learn more about Impel NeuroPharma, please visit our website at http://impelnp.com.
View Top Employees from Impel NeuroPharmaWebsite | http://www.impelnp.com |
Ticker | IMPL |
Revenue | $19 million |
Funding | $268.9 million |
Employees | 124 (124 on RocketReach) |
Founded | 2008 |
Address | 201 Elliott Ave W, Ste 260, Seattle, Washington 98119, US |
Phone | (206) 568-1466 |
Technologies |
JavaScript,
HTML,
PHP
+46 more
(view full list)
|
Industry | Drug Manufacturing & Research, Drug Discovery, Intranasal Drug Delivery, Pharmaceuticals, Drug Delivery, Bypassing the Blood Brain Barrier, Healthcare, Business Services |
Web Rank | 6 Million |
Keywords | Impel Neuropharma, Impel Neuropharma Compensation Committee Composition, Impel Neuropharma Careers, Impel, Impel Neuropharma Investors |
Competitors | Angiochem, Boston Life Sciences Inc, GlycoMimetics, Graybug Vision, Inc., Rexahn Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Impel NeuroPharma employee's phone or email?
The Impel NeuroPharma annual revenue was $19 million in 2024.
Adrian Adams is the Chairman and Chief Executive Officer of Impel NeuroPharma.
124 people are employed at Impel NeuroPharma.
Impel NeuroPharma is based in Seattle, Washington.
The NAICS codes for Impel NeuroPharma are [32, 325, 3254, 32541].
The SIC codes for Impel NeuroPharma are [283, 28].